DelMar Pharma ($DMPI) develops #cancer therapies in new indications where patients have failed or are unlikely to respond to modern therapy. #Glioblastoma
It was an honor to present an update on @DelMarPharma's ongoing clinical trials of VAL-083 at #AACR18 with my Co-Founder and Chief Scientific Officer Dr. Dennis Brown. $DMPI
We have demonstrated VAL-083's ability to overcome resistance with the MGMT enzyme which is associated with poor patient outcomes in #glioblastoma. Learn more: https://t.co/00Jl0tR23Q $DMPI
Glioblastoma is an aggressive primary brain tumor and is considered a rare disease. Learn more for today's @RareDiseaseDay: https://t.co/PJ9NhyYKrH @RareDiseases#ShowYourRare
This year's @RareDiseaseDay theme is research which highlights the need to discover and develop treatments and cures for #RareDiseases. Learn more here: https://t.co/IaEeHNEj22
The Ziemer family is launching a foundation to help children who lose siblings in honor of their daughter Marlena, who passed away from a #BrainTumor 3 years ago, and to celebrate the life of her older sister. Watch their feature on @WMTWTV: https://t.co/sEpZW3Uzp7
Watch and share the official Rare Disease Day 2018 video now! Available in over 30 languages: https://t.co/9p41XpGyCh #ShowYourRare https://t.co/AkSGlnMhJj
1 in 75 women will be diagnosed with #OvarianCancer during their lifetimes. Are you at risk? Find the risk factors here from @NOCC_National: https://t.co/Nmm0cpezgD
We have new resources that address the questions you may have about brain tumors from the worry about persistent symptoms, to what do after surgery. Even recurrence and other tough topics are covered. https://t.co/jT9F4KAcqL https://t.co/wG1Z5SpFkz